Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

2020386 citationsJournal Articlebronze Open Access

Authors

Simultaneous inhibition of EGFR and BRAF combined with irinotecan is effective in BRAFV600E-mutated CRC.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 39, Issue 4, pp. 285-294

Field-Weighted Citation Impact: 16.65